Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 21;106(11):e4542-e4553.
doi: 10.1210/clinem/dgab461.

Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women

Affiliations

Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women

Tess V Clendenen et al. J Clin Endocrinol Metab. .

Abstract

Context: We previously reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies.

Objective: This study assessed whether risk factors for breast cancer are correlates of AMH concentration.

Methods: This cross-sectional study included 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49) from 10 cohort studies among the general population.

Results: Adjusting for age and cohort, AMH positively associated with age at menarche (P < 0.0001) and parity (P = 0.0008) and inversely associated with hysterectomy/partial oophorectomy (P = 0.0008). Compared with women of normal weight, AMH was lower (relative geometric mean difference 27%, P < 0.0001) among women who were obese. Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P < 0.0001). We observed higher AMH concentrations among women who had had a benign breast biopsy (15% higher, P = 0.03), a surrogate for benign breast disease, an association that has not been reported. In analyses stratified by age (<40 vs ≥40), associations of AMH with body mass index and OCs were similar in younger and older women, while associations with the other factors (menarche, parity, hysterectomy/partial oophorectomy, smoking, and benign breast biopsy) were limited to women ≥40 (P-interaction < 0.05).

Conclusion: This is the largest study of AMH and breast cancer risk factors among women from the general population (not presenting with infertility), and it suggests that most associations are limited to women over 40, who are approaching menopause and whose AMH concentration is declining.

Keywords: AMH correlates; anti-Müllerian hormone; breast cancer risk factors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Age- and cohort-adjusted geometric mean AMH concentration (pmol/L) by individual characteristics. Note: P values are from the ANOVA F-tests for differences across categories. Ptrend for ordered categories are shown for BMI, age at menarche, parity, and age at first full-term pregnancy. All models are adjusted for age, age-squared, and cohort.

Similar articles

Cited by

References

    1. Ge W, Clendenen TV, Afanasyeva Y, et al. . Circulating anti-Müllerian hormone and breast cancer risk: a study in ten prospective cohorts. Int J Cancer. 2018;142(11):2215-2226. - PMC - PubMed
    1. Nichols HB, Baird DD, Stanczyk FZ, et al. . Anti-Mullerian hormone concentrations in premenopausal women and breast cancer risk. Cancer Prev Res. 2015;8(6):528-534. - PMC - PubMed
    1. Eliassen AH, Zeleniuch-Jacquotte A, Rosner B, Hankinson SE. Plasma anti-mullerian hormone concentrations and risk of breast cancer among premenopausal women in the nurses’ health studies. Cancer Epidemiol Biomark Prev. 2016;25(5):854-860. - PMC - PubMed
    1. Dorgan JF, Stanczyk FZ, Egleston BL, et al. . Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. J Natl Cancer Inst. 2009;101(21):1501-1509. - PMC - PubMed
    1. Dólleman M, Verschuren WM, Eijkemans MJ, et al. . Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98(5):2106-2115. - PubMed

Publication types